Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents

Fig. 2

Biocompatibility studies of polyanionic carbosilane dendrimers (PCDs). a MTT and b LDH assays were performed in MRC-5 cells for 6 days treatments. MRC-5 cells were treated with increased concentration range (1 µM – 50 µM) of G1-S4, G2-S16 or G2-S24P PCD. Non-treated (NT) MRC-5 cells were used as cell viability control. DMSO was used as cell death control. NT, non-treated control; DMSO, Dimethyl sulfoxide. The mean values (mean ± SD) of at least three independent experiments are shown (*p < 0.05; **p < 0.005; ***p < 0.001)

Back to article page